Target intelligence / Profile preview

Chromatin remodeling regulator CECR2 (CECR2)

Target
CECR2
Molecular classification
Bromodomain-containing protein, Chromatin remodeling factor, Histone acetyl-lysine reader, Transcription regulator
01

Overview

CECR2 is a bromodomain-containing protein that functions as a regulator within ATP-dependent chromatin remodeling complexes, especially the CERF-1 and CERF-5 ISWI complexes, which facilitate DNA access for replication, transcription, and repair. CECR2 binds acetylated and butyrylated lysine residues on histones, thus acting as a histone acetyl-lysine reader. It is essential for neurulation during embryogenesis, inner ear development, and spermatogenesis. Mutations or deletions in CECR2 are linked to Cat Eye Syndrome and have been associated with neurodevelopmental disorders including ASD. The protein also plays a role in DNA repair and apoptosis.

Other names
Cat eye syndrome critical region protein 2KIAA1740CECR2
02

Mechanism of action

Drugs targeting CECR2 would be expected to inhibit or modulate its bromodomain–histone acetyl-lysine binding activity, thereby affecting chromatin remodeling and gene expression (no approved drugs currently)

03

Biological functions

Chromatin remodelingDNA damage responseNeurulationTranscriptional regulationApoptosis execution phase
04

Disease associations

Cat Eye SyndromeAutism Spectrum Disorder (ASD)Anus imperforate (possible association)Cancer (emerging evidence)Neurodevelopmental disorders
05

Safety considerations

Potential concerns with targeting CECR2 include effects on development (neurulation, neural tube closure)spermatogenesisand possibly broad effects on gene expression leading to off-target effects or developmental toxicity

Beyond the preview

Go deeper on Chromatin remodeling regulator CECR2 (CECR2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromatin remodeling regulator CECR2 (CECR2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call